{"disease":{"id":"immune-thrombocytopenic-purpura","name":"immune thrombocytopenic purpura"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06727669","title":"Longitudinal Cohort of Thrombosis and Hemostasis Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT07426107","title":"Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Xiao Hui Zhang","has_results":false},{"nct_id":"NCT04057703","title":"Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.","phase":"","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06873672","title":"Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT00415532","title":"Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06722235","title":"A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":171,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06948318","title":"A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT04070612","title":"National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03524612","title":"A Study to Assess the Ability of Eltrombopag to Induce Sustained Response Off Treatment in Subjects With ITP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07150286","title":"Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Al-Mustansiriyah University","has_results":false},{"nct_id":"NCT04890041","title":"TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT01988506","title":"Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04056507","title":"Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT05585944","title":"\" Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura \"","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT02076399","title":"A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Rigel Pharmaceuticals","has_results":true},{"nct_id":"NCT04070599","title":"Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT01071954","title":"A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00157079","title":"Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT07310342","title":"Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":53,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03866577","title":"Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":50,"lead_sponsor_name":"Momenta Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02273960","title":"Study to Evaluate Safety and Efficacy in Adult Subjects With ITP","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT04428255","title":"A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Harbour BioMed (Guangzhou) Co. Ltd.","has_results":false},{"nct_id":"NCT06444477","title":"Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT00162006","title":"Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic Purpura","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Baxalta now part of Shire","has_results":false},{"nct_id":"NCT06523088","title":"A Study of PN20 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT07441525","title":"UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT00621894","title":"Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04323748","title":"Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT06831058","title":"A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04588194","title":"Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"David Gomez Almaguer","has_results":false},{"nct_id":"NCT05263193","title":"Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)","phase":"","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05393999","title":"SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":false},{"nct_id":"NCT03363334","title":"Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Rigel Pharmaceuticals","has_results":false}],"total":33},"guidelines":[],"source":"Drug Landscape verified database"}